A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Clinical trial NCT05833763 · RECRUITING
Trial details
- NCT number
- NCT05833763
- Sponsor
- Australasian Leukaemia and Lymphoma Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-12
- Primary completion
- 2032-04-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.